Camrelizumab combined with chemotherapy followed by maintenance camrelizumab and apatinib as first-line therapy for extensive-stage small cell lung cancer: A phase II, single-arm, exploratory study.
Objectives We use new data and robust methods to estimate mortality levels and trends for US states and Washington DC and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results